Target
Egl nine homolog 1 [181-417]
Ligand
BDBM475396
Substrate
n/a
Meas. Tech.
Enzyme Activity Assay
IC50
158±n/a nM
Citation
 Hocutt, FMLeonard, Jr., BEPeltier, HMPhuong, VKRabinowitz, MHRosen, MDTarantino, KTVenkatesan, HZhao, LX Benzoimidazoles as prolyl hydroxylase inhibitors US Patent  US10851083 Publication Date 12/1/2020 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM475396
Synonyms:
1-(4-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)- | US10851083, Example 8 | US11618744, Example 8
Type:
Small organic molecule
Emp. Form.:
C12H6ClF3N4O2
Mol. Mass.:
330.65
SMILES:
OC(=O)c1cnn(c1)-c1nc2c(Cl)cc(cc2[nH]1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: